Mariani J. Peter's Insider Trades & SAST Disclosures
Mariani J. Peter's most recent trade in Cytosorbents Corp was a trade of 32,625 Series A Right Warrants (right to buy) done . Disclosure was reported to the exchange on Feb. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mariani J. Peter.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | 24 Feb 2025 | 32,625 | 0 | - | - | Series A Right Warrants (right to buy) | ||
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | 24 Feb 2025 | 32,625 | 466,613 (1%) | 0% | 1.1 | 36,866 | Common Stock | |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 32,625 | 32,625 | - | - | Series B Right Warrants | |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | 17 Jan 2025 | 32,625 | 433,988 (1%) | 0% | 1 | 32,625 | Common Stock | |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | 17 Jan 2025 | 32,625 | 0 | - | - | Subscription Rights (right to buy) | ||
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 32,625 | 32,625 | - | - | Series A Right Warrants | |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 13 Dec 2024 | 20,000 | 401,363 (1%) | 0% | 1.0 | 19,294 | Common Stock |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 11 Dec 2024 | 20,000 | 381,363 (1%) | 0% | 0.9 | 17,872 | Common Stock |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 11 Dec 2024 | 11,363 | 361,363 (1%) | 0% | 0.9 | 10,103 | Common Stock |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 215,000 | 215,000 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 175,000 | 350,000 (0%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 110,000 | 110,000 (0%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 65,000 | 175,000 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | J. Peter Mariani | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.50 per share. | 11 Dec 2023 | 7,970 | 63,603 (0%) | 0% | 7.5 | 59,775 | Common Stock |
| Axogen Inc. | J. Mariani Peter | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.51 per share. | 11 Dec 2023 | 3,120 | 71,573 (0%) | 0% | 7.5 | 23,431 | Common Stock |
| Axogen Inc. | Mariani J. Peter | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.52 per share. | 11 Dec 2023 | 1,410 | 74,693 (0%) | 0% | 7.5 | 10,603 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 94,500 | 94,500 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 65,600 | 65,600 | - | - | Restricted Stock Units | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 15,250 | 15,250 | - | - | Restricted Stock Units | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 15,250 | 80,829 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 5,500 | 5,500 | - | - | Restricted Stock Units | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 5,500 | 67,445 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share. | 16 Mar 2023 | 5,172 | 75,657 (0%) | 0% | 8.3 | 42,772 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share. | 16 Mar 2023 | 1,866 | 65,579 (0%) | 0% | 8.3 | 15,432 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 30 Jan 2023 | 20,940 | 76,495 (0%) | 0% | 5.0 | 105,538 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 20,940 | 0 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 20,939 | 20,940 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 20,939 | 41,879 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 30 Jan 2023 | 20,939 | 63,047 (0%) | 0% | 5.0 | 105,533 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 30 Jan 2023 | 20,939 | 69,875 (0%) | 0% | 5.0 | 105,533 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.36 per share. | 30 Jan 2023 | 14,550 | 61,945 (0%) | 0% | 9.4 | 136,188 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.55 per share. | 30 Jan 2023 | 14,320 | 55,555 (0%) | 0% | 9.6 | 136,756 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.69 per share. | 30 Jan 2023 | 14,111 | 48,936 (0%) | 0% | 9.7 | 136,736 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.16 per share. | 25 Jan 2023 | 20,940 | 42,108 (0%) | 0% | 10.2 | 212,750 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 20,940 | 62,818 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 25 Jan 2023 | 20,940 | 63,048 (0%) | 0% | 5.0 | 105,538 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 20,939 | 83,758 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 25 Jan 2023 | 20,939 | 63,047 (0%) | 0% | 5.0 | 105,533 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.23 per share. | 25 Jan 2023 | 20,939 | 42,108 (0%) | 0% | 10.2 | 214,206 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 25 Jan 2023 | 20,939 | 63,047 (0%) | 0% | 5.0 | 105,533 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.90 per share. | 25 Jan 2023 | 20,939 | 42,108 (0%) | 0% | 9.9 | 207,296 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 20,939 | 104,697 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2022 | 2,625 | 42,757 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2022 | 2,625 | 2,625 | - | - | Restricted Stock Units | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.44 per share. | 27 Dec 2022 | 649 | 42,108 (0%) | 0% | 9.4 | 6,127 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 14 Dec 2022 | 19,364 | 49,062 (0%) | 0% | 5.0 | 97,595 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2022 | 19,364 | 185,636 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.93 per share. | 14 Dec 2022 | 8,930 | 40,132 (0%) | 0% | 10.9 | 97,605 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.88 per share. | 16 Nov 2022 | 10,649 | 29,698 (0%) | 0% | 11.9 | 126,510 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 3,710 | 38,294 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Sale or transfer of securities back to the company at price $ 8.40 per share. | 18 Jul 2022 | 947 | 40,347 (0%) | 0% | 8.4 | 7,955 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 103,079 | 103,079 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 76,780 | 76,780 | - | - | Restricted Stock Units | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 11,000 | 37,353 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 11,000 | 11,000 | - | - | Restricted Stock Units | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share. | 16 Mar 2022 | 2,769 | 34,584 (0%) | 0% | 8.0 | 22,069 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 3,157 | 27,303 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share. | 15 Feb 2022 | 950 | 26,353 (0%) | 0% | 8.4 | 7,999 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2021 | 2,625 | 24,794 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2021 | 2,625 | 2,625 | - | - | Restricted Stock Units | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share. | 27 Dec 2021 | 648 | 24,146 (0%) | 0% | 9.7 | 6,312 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 1,900 | 22,926 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 1,900 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.24 per share. | 20 Dec 2021 | 757 | 22,169 (0%) | 0% | 9.2 | 6,995 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 3,710 | 21,944 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.20 per share. | 19 Jul 2021 | 918 | 21,026 (0%) | 0% | 19.2 | 17,626 | Common Stock |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 61,000 | 61,000 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Peter J. Mariani | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 30,500 | 30,500 | - | - | Restricted Stock Units | |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 7,655 | 18,031 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 3,157 | 19,023 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.71 per share. | 16 Feb 2021 | 2,165 | 15,866 (0%) | 0% | 18.7 | 40,507 | Common Stock |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.70 per share. | 16 Feb 2021 | 789 | 18,234 (0%) | 0% | 18.7 | 14,754 | Common Stock |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2020 | 5,250 | 11,669 (0%) | 0% | - | Common Stock | |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.81 per share. | 27 Dec 2020 | 1,293 | 10,376 (0%) | 0% | 17.8 | 23,028 | Common Stock |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2020 | 1,900 | 6,900 (0%) | 0% | - | Common Stock | |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.42 per share. | 18 Dec 2020 | 481 | 6,419 (0%) | 0% | 16.4 | 7,898 | Common Stock |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.41 per share. | 30 Oct 2020 | 60,000 | 20,683 (0%) | 0% | 12.4 | 744,720 | Common Stock |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2020 | 60,000 | 145,000 | - | - | Employee Stock Options (Right to Purchase) | |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 30 Oct 2020 | 60,000 | 80,683 (0%) | 0% | 5.0 | 302,400 | Common Stock |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.41 per share. | 30 Oct 2020 | 12,854 | 6,745 (0%) | 0% | 12.4 | 159,518 | Common Stock |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.41 per share. | 30 Oct 2020 | 1,745 | 5,000 (0%) | 0% | 12.4 | 21,662 | Common Stock |
| Axogen Inc. | Peter J. Mariani | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.41 per share. | 30 Oct 2020 | 1,084 | 19,599 (0%) | 0% | 12.4 | 13,452 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges